This device was used for treatment, not diagnosis.(b)(4).Device is an instrument and is not implanted/explanted.(b)(6).The device was received, the investigation could not be completed, and no conclusion could be drawn, as product is entering the complaint system.Part #: 351.709s, lot#: h080083 (sterile) - 2.5mm reaming rod with ball tip/650mm-sterile.Quantity (b)(4).No ncrs were generated during production.Review of the device history record(s) showed that there were no issues during the manufacture of the product that would contribute to this complaint condition.Sterility documentation was reviewed and determined to be conforming.Investigation summary shows, the devices were received with the clear mylar web of the sterile packaging delaminating (fused layers separated).The reaming rods were undamaged.An investigation by the supplier confirmed the issue and found a deviation with the pouch's material supplier.The investigation is confirmed and further investigation is being documented under ((b)(6)'s internal non-conformance system).The preliminary investigation by the pouch manufacturer and tier 2 material supplier, the issue is believed to affect a limited number of pouches which were manufactured using a specific raw material lot from tier 2 supplier (b)(6).A quality event occurred during the manufacture of this lot of raw material and this has been confirmed by (b)(6).(b)(6) has procedures in place to ensure culling of all affected material when a quality event occurs.However an escape is suspected of occurring during manufacture of this lot.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
Device report from synthes (b)(4) reports an event as follows: it was reported that during a procedure, it was difficult to open the packaging for the reaming rod as it was torn and split.The reaming rod was unusable, the surgery was prolonged about 15 minutes with risk of cancellation if another reaming rod product is not available.This report is 1 of 1 for (b)(4).
|
A product investigation was completed: the devices were received with the clear mylar web of the sterile packaging delaminating (fused layers separated).The reaming rods were undamaged.An investigation by the supplier confirmed the issue and found a deviation with the pouch's material supplier.The investigation is confirmed.Preliminary investigation by the pouch manufacturer and tier 2 material supplier, the issue is believed to affect a limited number of pouches which were manufactured using a specific raw material lot from tier 2 supplier (b)(4).A quality event occurred during the manufacture of this lot of raw material and this has been confirmed by (b)(4).(b)(4) has procedures in place to ensure culling of all affected material when a quality event occurs.This is a confirmed manufacturing issue, and steps have been taken to address it.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|